0001209191-22-009349.txt : 20220214
0001209191-22-009349.hdr.sgml : 20220214
20220214165128
ACCESSION NUMBER: 0001209191-22-009349
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220211
FILED AS OF DATE: 20220214
DATE AS OF CHANGE: 20220214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dasu Badri N
CENTRAL INDEX KEY: 0001310803
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35068
FILM NUMBER: 22633841
MAIL ADDRESS:
STREET 1: C/O ACELRX PHARMACEUTICALS, INC.
STREET 2: 351 GALVESTON DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACELRX PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001427925
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 25821 INDUSTRIAL BOULEVARD
STREET 2: SUITE 400
CITY: HAYWARD
STATE: CA
ZIP: 94545
BUSINESS PHONE: 650-216-3500
MAIL ADDRESS:
STREET 1: 25821 INDUSTRIAL BOULEVARD
STREET 2: SUITE 400
CITY: HAYWARD
STATE: CA
ZIP: 94545
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-11
0
0001427925
ACELRX PHARMACEUTICALS INC
ACRX
0001310803
Dasu Badri N
C/O ACELRX PHARMACEUTICALS, INC.
25821 INDUSTRIAL BLVD., SUITE 400
HAYWARD
CA
94545
0
1
0
0
Chief Engineering Officer
Common Stock
2022-02-11
4
A
0
97500
0.00
A
301822
D
Common Stock
2022-02-11
4
F
0
5615
0.4014
D
296207
D
Stock Option (Right to Buy)
0.4014
2022-02-11
4
A
0
195000
0.00
A
2032-02-11
Common Stock
195000
195000
D
The restricted stock units shall vest in three equal consecutive annual installments on February 11, 2023, February 11, 2024 and February 11, 2025.
Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.
On February 11, 2022, the reporting person was granted an option to purchase 195,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods.
/s/ Martha Adler, Attorney-In-Fact
2022-02-14